Brochure
31 Jan 2023
Guide to sustainable labeling for pharmaceutical and healthcare applications

Content provided by our supplier
UPM RAFLATAC CHINA

-
FI
-
2016On CPHI since
-
1000 - 4999Employees
Company types
Primary activities
Other Content from UPM RAFLATAC CHINA (1)
-
Whitepaper Migration safe pharmaceutical labels improve product safety
Low-performance labels that create leachable chemical compounds may fail testing or perform poorly across your pharmaceutical product’s lifecycle, resulting in significant launch delays or costly recalls.
This white paper created by pharmaceutical packaging experts walks you through the key steps in ensuring migration-safe packaging and labels.
Learn in this comprehensive white paper:
What is primary, secondary, and tertiary pharmaceutical packaging?
Glass vs. plastic packaging - what are the pros & cons?
What key regulations for pharmaceutical packaging must I take into account?
How and why can label materials leach into packaging forms?
What drug packaging does the FDA classify as high-risk for leaching?
How can I streamline packaging testing to speed up product launches?
What industry best practices should I adhere to, such as change management procedures?
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance